title: Reply to Drs Hiraizumi and Suzuki.
authors.forename: C
authors.initials: C
authors.lastname: Phaloprakarn
authors.forename: S
authors.initials: S
authors.lastname: Tangjitgamol
mesh_terms: D000017:ABO Blood-Group System / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007236:Infant, Small for Gestational Age; D011247:Pregnancy; D011248:Pregnancy Complications / Q000209:etiology*; D011256:Pregnancy Outcome
chemical_list: D000017:ABO Blood-Group System